Table 2 Evolution of the hemodynamic characteristics during the study

Concerned patients number

24

24

23

19

Heart rate (beats/min)

102 ± 22

102 ± 23

102 ± 23

102 ± 24

Systolic arterial pressure (mmHg)

120 ± 18

119 ± 23

119 ± 19

116 ± 17

Diastolic arterial pressure (mmHg)

62 ± 11

63 ± 12

65 ± 11

62 ± 11

Mean arterial pressure (mmHg)

81 ± 11

81 ± 13

80 ± 14

80 ± 12

Pulse pressure (mmHg)

57 ± 13

56 ± 17

54 ± 17

54 ± 13

Cardiac index (L min⁻¹ m⁻²) (TPTD)

3.7 ± 1.1^b,c,d

3.3 ± 1.3^a

3.3 ± 1.2^a

3.1 ± 1.1^a

SVI (mL min⁻¹ m⁻²) (TPTD)

36 ± 11^b,c,d

33 ± 14^a

33 ± 14^a

32 ± 14^a

GEDI (mL min⁻¹ m⁻²) (TPTD)

680 ± 140^b,c,d

634 ± 134^a

646 ± 126^a

625 ± 112^a

CFI (min⁻¹) (TPTD)

5.5 ± 1.8^b,c,d

5.2 ± 1.9^a

5.0 ± 1.8^a

5.0 ± 1.5^a

LVEF (%) (TTE)

53 ± 16^b,c,d

50 ± 17^a

49 ± 15^a

49 ± 13^a

RVEDA/LVEDA ratio (TTE)

0.61 ± 0.15^b,c,d

0.70 ± 0.18^a

0.72 ± 0.18^a

0.67 ± 0.14^a

RVEDA/LVEDA ratio >0.6 [n (%)]

11 (46)^b,c

17 (71)^a,d

17 (74)^a,d

10 (53)^b,c

ACP echocardiographic pattern [n (%)]

5 (21)^b,c

11 (46)^a,d

10 (43)^a,d

6 (32)^b,c

LVOT VTI (cm) (TTE)

17 ± 5^b,c,d

14 ± 5^a

14 ± 5^a

14 ± 5^a

E-wave (cm s⁻¹) (TTE)

90 ± 23^c

86 ± 20^c

80 ± 21^a,b,d

91 ± 22^c

A-wave (cm s⁻¹) (TTE)

57 ± 16

58 ± 12

54 ± 12

57 ± 15

E′ (cm s⁻¹) (TTE)

14 ± 5

14 ± 5

14 ± 4

15 ± 5

DTE (ms) (TTE)

207 ± 51

204 ± 44

213 ± 38

205 ± 46

E/A (TTE)

1.8 ± 0.5^b,c

1.6 ± 0.6^a

1.6 ± 0.5^a

1.8 ± 0.7^b,c

E/E′ (TTE)

8.3 ± 2.9

8.4 ± 2.9

7.4 ± 3.6

8.0 ± 3.0

Norepinephrine (μg kg⁻¹ min⁻¹)

0.59 ± 0.78

0.59 ± 0.78

0.58 ± 0.78

0.53 ± 0.69